354 related articles for article (PubMed ID: 2933181)
21. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
22. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
Ylikorkala O; Puolakka J; Viinikka L
Am J Obstet Gynecol; 1982 Mar; 142(5):573-6. PubMed ID: 7036746
[TBL] [Abstract][Full Text] [Related]
23. Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease.
Buchanan MR; Butt RW; Turpie AG
Am Heart J; 1987 May; 113(5):1133-7. PubMed ID: 2953219
[TBL] [Abstract][Full Text] [Related]
24. Smoke-derived nitric oxide and vascular prostacyclin are unable to counteract the platelet effect of increased thromboxane formation in healthy female smokers.
Rångemark C; Wennmalm A
Clin Physiol; 1996 May; 16(3):301-15. PubMed ID: 8736716
[TBL] [Abstract][Full Text] [Related]
25. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
Gryglewski RJ; Dembínska-Kieć A; Korbut R
Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandins and platelet aggregation.
Smith JB
Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris.
Kishi Y; Ashikaga T; Numano F
Am Heart J; 1992 Feb; 123(2):291-7. PubMed ID: 1736562
[TBL] [Abstract][Full Text] [Related]
28. The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.
Levin RI; Weksler BB; Jaffe EA
Circulation; 1982 Dec; 66(6):1299-307. PubMed ID: 6291803
[TBL] [Abstract][Full Text] [Related]
29. Platelet prostacyclin binding in coronary artery disease.
Jaschonek K; Karsch KR; Weisenberger H; Tidow S; Faul C; Renn W
J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061
[TBL] [Abstract][Full Text] [Related]
30. Abnormal typical pattern of platelet function and thromboxane generation in unstable angina.
Zahavi M; Zahavi J; Schafer R; Firsteter E; Laniado S
Thromb Haemost; 1989 Nov; 62(3):840-5. PubMed ID: 2531938
[TBL] [Abstract][Full Text] [Related]
31. [Effects of Ligusticum wallichii on the plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2 and 6-keto-PGF1 alpha in patients with acute cerebral infarction].
Liu Z
Zhong Xi Yi Jie He Za Zhi; 1991 Dec; 11(12):711-3, 707. PubMed ID: 1840363
[TBL] [Abstract][Full Text] [Related]
32. Evidence for isosorbide dinitrate (ISDN) promoting effect on prostacyclin release by the lung and prostacyclin implication in ISDN-induced inhibition of platelet aggregation in humans.
Rolland PH; Bory M; Leca F; Sainsous J; Gueydon E; Juhan I; Serradimigni A; Cano JP
Prostaglandins Leukot Med; 1984 Dec; 16(3):333-46. PubMed ID: 6396656
[TBL] [Abstract][Full Text] [Related]
33. Effects of bopindolol on platelet function in hypertension at rest and during exercise.
Virgolini I; Fitscha P; Rauscha F; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):125-30. PubMed ID: 2143586
[TBL] [Abstract][Full Text] [Related]
34. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
Ylikorkala O; Saarela E; Viinikka L
J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
[TBL] [Abstract][Full Text] [Related]
35. Increased platelet activity after termination of prostacyclin infusion into man.
Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
[TBL] [Abstract][Full Text] [Related]
36. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Nidorf SM; Sturm M; Strophair J; Kendrew PJ; Taylor RR
Cardiovasc Res; 1989 Apr; 23(4):273-8. PubMed ID: 2590911
[TBL] [Abstract][Full Text] [Related]
37. Effects of quercetin on platelet and reperfusion-induced arrhythmias in rats.
Xiao D; Gu ZL; Qian ZN
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):505-8. PubMed ID: 8010047
[TBL] [Abstract][Full Text] [Related]
38. Fish oil administration as a supplement to a corn oil containing diet affects arterial prostacyclin production more than platelet thromboxane formation in the rat.
Socini A; Galli C; Colombo C; Tremoli E
Prostaglandins; 1983 May; 25(5):693-710. PubMed ID: 6310702
[TBL] [Abstract][Full Text] [Related]
39. Central haemodynamic and antiplatelet effects of iloprost--a new prostacyclin analogue--in acute myocardial infarction in man.
Swedberg K; Held P; Wadenvik H; Kutti J
Eur Heart J; 1987 Apr; 8(4):362-8. PubMed ID: 2440682
[TBL] [Abstract][Full Text] [Related]
40. Ticlopidine activity on platelet function in patients with enhanced platelet aggregation. A short-term crossover study.
Gensini GF; Favilla S; Breschi C; Abbate R; Costanzo G; Neri Serneri GG
Haemostasis; 1983; 13(5):294-300. PubMed ID: 6228500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
